文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

整合分析识别脓毒症心肌病中乳酸化相关核心基因

Integrative Analysis Identifies Lactylation-Associated Hub Genes in Septic Cardiomyopathy.
PubMed 文献 · Shock · 2026-03-12
一句话结论生物信息学分析提示GADD45B、STAT3、SLC7A5为脓毒症心肌病核心基因,与乳酸化调控相关。

本研究利用GSE79962公共转录组数据,通过加权基因共表达网络分析、三种机器学习算法(Boruta、随机森林、SVM-RFE)筛选脓毒症心肌病核心基因,并用ROC曲线评估诊断价值,同时进行功能通路富集、免疫浸润分析和蛋白互作网络构建。结果识别出GADD45B、STAT3、SLC7A5三个核心基因,其AUC均超过0.95, innate免疫和炎症通路显著激活,心脏能量代谢通路持续抑制,且与cS-STING信号通路及多种免疫细胞浸润相关。这些基因的异常表达在脂多糖诱导的脓毒症小鼠模型心脏组织中得到验证。研究提出乳酸化调控这些核心基因可能是未来机制研究的新假设。

要点

  • 在GSE79962转录组数据中,GADD45B、STAT3、SLC7A5三个核心基因在脓毒症心肌病中显著失调,ROC曲线AUC均超过0.95。
  • 基因集富集分析显示脓毒症心肌病中先天免疫和炎症通路显著激活,同时心脏关键能量代谢通路持续抑制。
  • 核心基因与cS-STING信号通路密切相关,其表达水平与静息自然杀伤细胞、M0和M2巨噬细胞、静息CD4+记忆T细胞等免疫细胞亚群浸润显著相关。
  • 在脂多糖诱导的脓毒症小鼠模型心脏组织中,上述核心基因的异常表达得到实验验证。
  • 作者提出乳酸化调控这些核心基因是未来机制研究的新假设,需进一步研究。

研究设计与关键结果

  • 研究类型为生物信息学分析加脂多糖诱导脓毒症小鼠模型实验验证,使用公共人类转录组数据集GSE79962。
  • 通过加权基因共表达网络分析、Boruta、随机森林和SVM-RFE三种机器学习算法联合筛选出GADD45B、STAT3、SLC7A5三个核心基因,在脓毒症心肌病中显著失调。
  • 三个核心基因诊断价值突出,ROC曲线下面积AUC均超过0.95。
  • 基因集富集分析显示先天免疫和炎症通路显著激活,心脏关键能量代谢通路持续抑制。
  • 核心基因与cS-STING信号通路密切关联,其表达与静息自然杀伤细胞、M0和M2巨噬细胞、静息CD4+记忆T细胞浸润显著相关。
  • 在脂多糖诱导的脓毒症小鼠模型心脏组织中验证了核心基因的异常表达。

证据类型、等级与局限

  • 证据类型:生物信息学分析结合动物实验验证。
  • 作者提出乳酸化调控核心基因是未来机制研究的新假设。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Septic cardiomyopathy (SCM) is a critical complication contributing to high mortality in septic patients, yet its precise molecular mechanisms remain incompletely elucidated.

METHODS: Publicly available human transcriptomic data for SCM were obtained from the Gene Expression Omnibus database (GSE79962). Our integrated analytical workflow consisted of several steps. First, Weighted Gene Co-expression Network Analysis pinpointed key co-expression modules. Subsequently, a consensus approach combining three machine learning algorithms, Boruta, Random Forest, and Support Vector Machine-Recursive Feature Elimination, was used to screen for hub genes. The diagnostic potential of these genes was then assessed using receiver operating characteristic curves. Further investigations included functional pathway enrichment via Gene Set Enrichment Analysis, immune infiltration profiling with CIBERSORT, and the construction of a protein-protein interaction network using the STRING database. To validate the bioinformatic findings, key results were experimentally confirmed in a lipopolysaccharide-induced septic mouse model.

RESULTS: Our analysis identified three hub genes [growth arrest and DNA damage-inducible protein 45 beta (GADD45B), signal transducer and activator of transcription 3 (STAT3), and solute carrier family 7 member 5 (SLC7A5)] that were significantly dysregulated in SCM. These genes demonstrated exceptional diagnostic power, with area under the curve values exceeding 0.95. Gene set enrichment analysis indicated a pronounced activation of innate immune and inflammatory pathways. Concurrently, we observed a sustained suppression of critical cardiac energy metabolic pathways. The hub genes were also closely linked to the cS-STING signaling pathway. Their expression levels showed significant correlations with the infiltration of specific immune cell subsets, including resting natural killer cells, M0 and M2 macrophages, and resting CD4+ memory T cells. Critically, the dysregulation of these hub genes was successfully corroborated in heart tissues from the lipopolysaccharide-induced mouse model.

CONCLUSIONS: This study, through integrated bioinformatics and initial experimental validation, identifies growth arrest and DNA damage-inducible protein 45 beta, signal transducer and activator of transcription 3, and solute carrier family 7 member 5 as central hub genes in SCM and proposes their potential regulation by lactylation as a novel hypothesis for future mechanistic investigation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Jin R, Dai J, Zhang X, et al. Integrative Analysis Identifies Lactylation-Associated Hub Genes in Septic Cardiomyopathy. Shock. 2026. PMID: 41886545. doi:10.1097/SHK.0000000000002819

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。